v3.26.1
Subsequent Events
6 Months Ended
Jun. 30, 2026
Subsequent Events [Abstract]  
Subsequent Events

11. Subsequent Events

The Company’s management evaluated subsequent events through the date on which the consolidated financial statements were issued. Except as noted below or already disclosed, there have been no subsequent events that occurred during such period that would require disclosure in the consolidated financial statements or would be required to be recognized in the consolidated financial statements as of and for the six months ended June 30, 2026.

Common Stock Issuance

 

On July 24, 2026, the Company issued approximately 3,705,229 shares of Common Stock, resulting in gross proceeds of approximately $90 million.

 

Distributions

On August 4, 2026, the Board of Directors of the Company authorized a cash distribution of $0.37 per share of the Company’s Common Stock, which the Company declared on August 5, 2026. The distribution is payable on August 14, 2026, to the holders of record of the Company’s Common Stock as of the close of business on August 7, 2026. Distributions will be paid in cash or reinvested in shares of Common Stock for Common Stockholders participating in the Company’s distribution reinvestment plan.

Investment Operations

As of August 5, 2026, the Company’s investment portfolio totaled $1,011.0 million across 28 portfolio companies, comprised of loan commitments of $951.6 million in aggregate principal amount, of which $759.8 million was funded and $191.8 million was unfunded, and a preferred equity investment of $59.4 million.

Recent Transactions

 

WillowWood - Switzerland BidCo LLC

On July 16, 2026, the Company closed a first lien credit facility for Switzerland BidCo LLC (“WillowWood”) backing an acquisition by a financial sponsor with loan commitments of $38.3 million in aggregate principal amount. WillowWood is a leading designer and manufacturer of prosthetic medical devices.

MB2 - MB2 Dental Solutions, LLC

On July 23, 2026, the Company entered into a secondary purchase of a first lien credit facility for MB2 Dental Solutions, LLC (“MB2”) with loan commitments of $50.0 million in aggregate principal amount. MB2 is a leading dental partnership organization.